Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Soichiro Saikawa
Sodium Glucose Cotransporter 2 Inhibitor Canagliflozin Attenuates Liver Cancer Cell Growth and Angiogenic Activity by Inhibiting Glucose Uptake
International Journal of Cancer
Cancer Research
Oncology
Related publications
Sodium Glucose Cotransporter-2 (SGLT-2) Inhibitor Related Diabetic Ketoacidosis
European Scientific Journal ESJ
Euglycemic Diabetic Ketoacidosis With Prolonged Glucosuria Associated With the Sodium-Glucose Cotransporter-2 Canagliflozin
Journal of Investigative Medicine High Impact Case Reports
Risk
Epidemiology
Reliability
Safety
Safety Research
Quality
Cardiovascular Effects of Sodium Glucose Cotransporter 2 Inhibitors
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Internal Medicine
Pharmacology
Increased Grip Strength With Sodium-Glucose Cotransporter 2
Journal of Diabetes
Endocrinology
Metabolism
Diabetes
Hemodynamic Effects of Sodium-Glucose Cotransporter 2 Inhibitors
Journal of Clinical Medicine Research
Heart Failure Prevention With Sodium‐glucose Cotransporter 2 Inhibitors
Journal of Diabetes
Endocrinology
Metabolism
Diabetes
Ertugliflozin: A Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitor for Glycemic Control in Type 2 Diabetes
Therapeutics and Clinical Risk Management
Sodium–Glucose Cotransporter Inhibitors: Effects on Renal and Intestinal Glucose Transport
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
The Sodium–Glucose Cotransporter 2 Inhibitor Dapagliflozin Prevents Cardiomyopathy in a Diabetic Lipodystrophic Mouse Model
Diabetes
Internal Medicine
Endocrinology
Metabolism
Diabetes